Booth No.1F-12
UBE offers total solution of APIs (and intermediates) production, for example, process optimization, preparation and submission of filing documents (e.g. DMFs), manufacturing based on cGMP and potent material handing (incl. pulverization). UBE had FDA pre-approval inspections (PAI) for brand-new drug’s APIs successfully. In addition, we introduce new building blocks which incorporate pentafluoro-sulfanyl (SF5) groups and nucleophilic fluorinating agent “FLUOLEAD(TM)“, that is applicable for the deoxo-fluorination reaction use, as alternatives of DAST and Sulfur tertrafluoride (SF4).

Corporate information

Address 105-8449
Seavans North Bldg., 1-2-1 Shibaura, Minato-ku, Tokyo JAPAN
TEL 81-3-5419-6178
FAX 81-3-5419-6257
URL http://www.ube.co.jp
Email 35200u@ube-ind.co.jp
Product Classification Contract Manufacturing of APIs and Intermediates
Nucleophilic fluorinating agent useful for deoxo-fluorination reactions, “FLUOLEAD(TM)“
N0.5 HPAPI Plant